Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males

Epidemiology and Infection

Volumn 136, Issue 3, 2008, Pages 421-431

  Pan, Yapan ^a,b   Jackson, R T ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FERRITIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FERRITIN BLOOD LEVEL; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERFERRITINEMIA; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEGRO; NEOPLASM; PATHOGENESIS; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOCYTE COUNT; UNITED STATES;

ACUTE-PHASE REACTION; ADULT; ETHNIC GROUPS; FERRITINS; HUMANS; MALE; NUTRITION SURVEYS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 39049105963     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880700831X     Document Type: Article

References (54)

1. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002; 99: 3505-3516.
2. Linert W, Jameson GNL. Redox reactions of neuro-transmitters possibly involved in the progression of Parkinson's Disease. Inorganic Biochemistry 2000; 79: 319-326.
3. Kondo T, et al. Embryonic genes expressed in Alzheimer's disease brains. Neuroscience Letters 1996; 209: 157-160.
4. Pang JH, et al. Increased ferritin gene expression in atherosclerotic lesions. Journal of Clinical Investigation 1996; 97: 2204-2212.
5. Ryan TP, et al. Pulmonary ferritin: Differential effects of hyperoxic lung injury on subunit mRNA levels. Free Radical Biology & Medicine 1997; 22: 901-908.
6. Biemond P, et al. Intraarticular ferritin-bound iron in rheumatoid arthritis - a factor that increases oxygen free radical-induced tissue destruction. Arthritis & Rheumatism 1986; 29: 1187-1193.
7. Ahmadzadeh N, et al. Correlation of metal-binding proteins and proteinase inhibitors with immunological parameters in rheumatoid synovial fluids. Clinical and Experimental Rheumatology 1990; 8 547-551.
8. Wu CG, et al. Rat ferritin-H: CDNA cloning, differential expression and localization during hepatocarcinogenesis. Carcinogenesis 1997; 18: 47-52.
9. Torti SV, et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. Journal of Biological Chemistry 1988; 263: 12 638-12 644.
10. Picard V, et al. Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution. Blood 1996; 87: 2057-2064.
11. Picard V, et al. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. Journal of Biological Chemistry 1998; 273: 15 382-15 386.
12. Risch N, et al. Categorization of humans in biomedical research: Genes, race and disease. Genome Biology 2002; 3: 1-12.
13. Ahern J, et al. Preterm birth among African-American and white women: A multilevel analysis of socio-economic characteristics and cigarette smoking. Journal of Epidemiology and Community Health 2003; 57: 606-611.
14. Simban HN, et al. Interleukin-6 promoter-174 polymorphism and spontaneous preterm birth. American Journal of Obstetrics and Gynecology 2003; 189: 915-918.
15. Wong MD, et al. Contribution of major diseases to disparities in mortality. New England Journal of Medicine 2002; 347: 1585-1592.
16. Padovani JC, et al. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thrombosis Research 2000; 100: 263-269.
17. Losito A, et al. Association of interleukin-6 -174G/C promoter polymorphism. with hypertension and left ventricular hypertrophy in dialysis patients. Kidney International 2003; 64 616-622.
18. Petri M. Epidemiology of systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 2002; 16: 847-858.
19. Hoffmann SC, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation 2002; 2: 560-567.
20. Biemond P, et al. Intraarticular ferritin-bound iron in rheumatoid arthritis: A factor that increases oxygen free radical induced tissue destruction. Arthritis & Rheumatism 1986; 29: 1187-1193.
21. National Center for Health Statistics, Centers for Disease Control Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Series 1: Programs and collection procedures. Vital Health Statistics 1994; 1: 1-407.
22. Barton JC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Annals of Internal Medicine 1998; 129: 932-939.
23. Young B, Gleeson M, Cripps AW. C-reactive protein: A critical review. Pathology 1991; 23: 118-124.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23 (Suppl. 1): S4-19.
25. Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. Journal of the American Medical Association 2003; 289: 2560-2571.
26. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Hyattsville: Centers for Disease Control and Prevention, 1996.
27. National Center for Health Statistics. Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III 1988-1994. October 1996.
28. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization, 1998.
29. Mainous AG 3rd, et al. Association of ferritin and lipids with C-reactive protein. American Journal of Cardiology 2004; 93: 559-562.
30. Williams DM. Racial differences of hemoglobin concentration: measurements of iron, copper, and zinc. American Journal of Clinical Nutrition 1981; 34: 1694-1700.
31. Jackson RT, et al. Comparison of hemoglobin values in black and white male U.S. military personnel. Journal of Nutrition 1983; 113: 165-171.
32. Bazzano GS, et al. Racial differences in iron-related hematological parameters. In: Iron Fortification Research on Iron Fortification and Iron Supplementation Conducted in the U.S., Touro Research Institute, New Orleans, LA, 1986, pp. 47-57.
33. Perry GS, et al. Iron nutrition does not account for the hemoglobin differences between blacks and whites. Journal of Nutrition 1992; 122: 1417-1424.
34. Muntanerelat J, et al. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995; 22: 1143-1153.
35. Cox ED, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001; 72: 720-726.
36. Hoffmann SC, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation 2002; 2: 560-567.
37. Ness RB, et al. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. American Journal of Epidemiology 2004; 160: 1033-1038.
38. Seedat YK. Varying responses to hypotensive agents in different racial groups: Black versus white differences. Journal of Hypertension 1989; 7: 515-518.
39. Weir MR, et al. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension 1995; 26: 124-130.
40. Lillie-Blanton M, et al. . Racial differences in health: Not just black and white, but shades of gray. Annual Review of Public Health 1996; 17: 411-448.
41. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclo-sporine. FK506 Kidney Transplant Study Group. Transplantation 1998; 65: 515-523.
42. Carson P, et al. Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. Journal of Cardiac Failure 1999; 5: 178-187.
43. Reddy KR, et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology 1999; 30: 787-793.
44. Di Bisceglie AM, et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial. Hepatology 2000; 32: 135-138.
45. Fontana RJ, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial. Hepatology 2000; 31: 730-736.
46. Clemente MG, et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. Journal of Pediatrics 1994; 125: 123-128.
47. Piperno A, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996; 16: 248-254.
48. Kageyama F, et al. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C. Biological Trace Element Research 1998; 64: 185-196.
49. Gillum RF, Mossolino ME, Madans JH. Coronary artery disease incidence and survival in African-American women and men: The NHANES I epidemiology follow-up study. Annals of Internal Medicin? 1997; 127: 111-118.
50. Sacco RL, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: The Northern Manhattan Stroke Study. American Journal of Epidemiology 1998; 147: 259-268.
51. Broderick J, et al. The greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998; 29: 415-421.
52. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Annals of Internal Medicine 1996; 125: 221-232.
53. Murrain M. Differential survival in blacks and Mexican Americans with AIDS. Ethnicity & Health 1996; 1: 373-382.
54. Parker SL, et al. Cancer statistics by race and ethnicity. CA: A Cancer Journal for Clinicians 1998; 48: 31-48.